Tesaro Announces Expanded Development Program For Cancer Drug Niraparib, Stock Spikes Higher
March 27, 2017 at 16:32 PM EDT
TESARO Inc (NASDAQ: TSRO) shares opened 3.25 percent higher after being halted around 3:30 p.m. ET. The company announced FDA approval ...